Global Imaging Biomarkers Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The global imaging biomarkers market size is expected to reach USD 55.45 Billion in 2034 from USD 18.83 Billion in 2025, growing at a CAGR of 12.75 during 2026-2034.This market is witnessing strong expansion due to the increasing use of advanced diagnostic imaging technologies across healthcare facilities worldwide. Imaging biomarkers are becoming essential for disease detection, treatment planning, and patient monitoring in areas such as oncology, neurology, and cardiology. Growing investments in precision medicine, rising clinical research activities, and the integration of artificial intelligence into imaging workflows are significantly enhancing diagnostic accuracy and efficiency, supporting continuous industry expansion across developed and emerging healthcare systems.

The growing burden of chronic diseases and the need for personalized treatment approaches are major factors driving industry development. Pharmaceutical companies increasingly rely on imaging biomarkers during clinical trials to evaluate therapeutic outcomes and improve drug development processes. Hospitals and diagnostic centers are adopting sophisticated imaging platforms to achieve faster and more reliable diagnoses. Government funding for medical research and technological advancements in MRI, CT, PET, and molecular imaging systems further strengthen overall industry progress.

Future prospects remain highly promising as healthcare providers continue adopting data-driven diagnostic solutions and non-invasive disease monitoring techniques. Advances in machine learning, cloud-based imaging analytics, and digital pathology are expected to improve biomarker interpretation and clinical decision-making. Expanding applications in rare diseases, neurodegenerative disorders, and precision oncology will create additional opportunities. Continuous collaboration between medical device manufacturers, research institutions, and pharmaceutical companies is expected to accelerate innovation and long-term commercial development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Biomarkers

Anatomical Biomarkers
Functional Biomarkers
Molecular/Nuclear Biomarkers
Quantitative Imaging Biomarkers
Others

By Imaging Technology

MRI
CT
PET
SPECT
Ultrasound
Others

By Application

Diagnostics
Drug Discovery & Development
Personalized Medicine
Disease Risk Assessment
Others

By End Use

Hospitals
Diagnostic/Imaging Centers
Pharmaceutical and Biotech Companies
Others

COMPANIES PROFILED

F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Hologic Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., PerkinElmer Inc., Brainomix Limited, IXICO plc, Median Technologies S.A.

Product Code: VMR112118761

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL IMAGING BIOMARKERS MARKET: BY BIOMARKERS 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Biomarkers
4.2. Anatomical Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Functional Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Molecular/Nuclear Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Quantitative Imaging Biomarkers Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMAGING BIOMARKERS MARKET: BY IMAGING TECHNOLOGY 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Imaging Technology
5.2. MRI Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. CT Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. PET Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. SPECT Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMAGING BIOMARKERS MARKET: BY APPLICATION 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Application
6.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Personalized Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Disease Risk Assessment Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMAGING BIOMARKERS MARKET: BY END USE 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End Use
7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Diagnostic/Imaging Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Pharmaceutical and Biotech Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IMAGING BIOMARKERS MARKET: BY REGION 2022-2034 (USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Biomarkers
- 8.2.2 By Imaging Technology
- 8.2.3 By Application
- 8.2.4 By End Use
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Biomarkers
- 8.3.2 By Imaging Technology
- 8.3.3 By Application
- 8.3.4 By End Use
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Biomarkers
- 8.4.2 By Imaging Technology
- 8.4.3 By Application
- 8.4.4 By End Use
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Biomarkers
- 8.5.2 By Imaging Technology
- 8.5.3 By Application
- 8.5.4 By End Use
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Biomarkers
- 8.6.2 By Imaging Technology
- 8.6.3 By Application
- 8.6.4 By End Use
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL IMAGING BIOMARKERS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 F. Hoffmann-La Roche AG
- 10.2.2 Abbott Laboratories
- 10.2.3 Thermo Fisher Scientific Inc
- 10.2.4 Siemens Healthineers AG
- 10.2.5 Hologic Inc
- 10.2.6 QIAGEN N.V
- 10.2.7 Bio-Rad Laboratories Inc
- 10.2.8 PerkinElmer Inc
- 10.2.9 Brainomix Limited
- 10.2.10 IXICO Plc
- 10.2.11 Median Technologies S.A